H. Nida Sen, MD, Mhs
About H. Nida Sen, MD, Mhs
H. Nida Sen, MD, MHS, is a Professor of Ophthalmology at The George Washington University, specializing in uveitis and clinical trials. With extensive training and experience, she leads translational research programs and provides clinical trial training while serving as a scientific advisor to various pharmaceutical companies.
Work at The George Washington University
H. Nida Sen, MD, MHS, has served as a Professor of Ophthalmology at The George Washington University since 2011. In this role, Sen contributes to the academic and clinical training of medical students and residents in the field of ophthalmology. The position involves directing Uveitis patient care services, where Sen oversees the treatment and management of patients with uveitis, a complex eye condition. The work at this institution is complemented by ongoing research and clinical trials focused on improving patient outcomes.
Education and Expertise
Sen's educational background includes a Doctor of Medicine (MD) from Hacettepe University and a Master's in Health Sciences (MHS) from Duke University, where Sen studied clinical trials. Additional training includes a residency in ophthalmology at The George Washington University School of Medicine and Health Sciences, completed from 2005 to 2008. Sen also pursued studies in clinical research at the University of Helsinki and completed a program in negotiation and influence at the MIT Sloan School of Management.
Professional Experience in Ophthalmology
Sen has held various leadership roles within the ophthalmology community, including serving as Chair of the Uveitis Subspecialty Day Planning Committee at the American Academy of Ophthalmology from 2017 to 2021. Additionally, Sen has been involved with the American Uveitis Society as President from 2021 to 2023. Sen has also contributed to the Association for Research in Vision and Ophthalmology (ARVO) as a mentor in their Leadership Development Program.
Clinical Research and Development
Sen is actively engaged in clinical research, leading a translational research program that focuses on immune-mediated and degenerative eye diseases, including uveitis, inherited retinal diseases (IRD), and age-related macular degeneration (AMD). As a Clinical Leader at Janssen Pharmaceutical Companies, Sen oversees clinical trials involving biologics, small molecules, and gene therapy. Sen also provides training in clinical trials for fellows, residents, and medical students, enhancing their research skills.
Editorial and Advisory Roles
Since 2020, Sen has been a member of the editorial board for the American Journal of Ophthalmology. In this capacity, Sen contributes to the peer-review process and helps shape the direction of published research in the field. Sen also serves as a scientific advisor to various pharmaceutical and biotech companies, offering expertise in therapeutics, biomarkers, and clinical trial design, thereby influencing the development of new treatments in ophthalmology.